Detalhe da pesquisa
1.
Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience.
Hematol Oncol
; 41(4): 621-630, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680368
2.
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.
Am J Hematol
; 99(5): 982-984, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343033
3.
PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes.
Am J Hematol
; 98(4): E72-E75, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695705
4.
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
Am J Hematol
; 98(9): E237-E240, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382471
5.
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study.
Br J Haematol
; 177(5): 741-750, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419408
6.
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.
Am J Hematol
; 92(10): 1037-1046, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28675513
7.
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Hematol Oncol
; 39(4): 570-574, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34258787
8.
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.
Haematologica
; 104(1): e4-e8, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076178
9.
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.
Cancers (Basel)
; 16(6)2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539561
10.
Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany.
Clin Exp Med
; 23(8): 4251-4264, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979127
11.
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia.
Haematologica
; 102(9): e332-e335, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522578
12.
Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience.
Transl Oncol
; 26: 101552, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183675
13.
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia.
Ther Adv Hematol
; 13: 20406207221127550, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36246422
14.
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study.
Front Oncol
; 12: 1033413, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479077
15.
Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis.
Br J Haematol
; 175(5): 975-979, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26773632
16.
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
Blood
; 122(13): 2286-8, 2013 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24072851
17.
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis.
Cancer Med
; 8(18): 7567-7576, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31657156
18.
Zinc Status and Autoimmunity: A Systematic Review and Meta-Analysis.
Nutrients
; 10(1)2018 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29324654
19.
Corrigendum to < Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience>.
Transl Oncol
; 30: 101631, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36801075
20.
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures.
Oncotarget
; 9(12): 10561-10571, 2018 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29535827